ArticleBMJ (Clinical research ed.)2002

Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified.

Hilary Calvert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.